Continuity of Visiting Pharmacist Services and Factors Related to Service Discontinuation Among Older Adults in Japan: A Retrospective Cohort Study
- PMID: 40650356
- PMCID: PMC12254188
- DOI: 10.1002/prp2.70152
Continuity of Visiting Pharmacist Services and Factors Related to Service Discontinuation Among Older Adults in Japan: A Retrospective Cohort Study
Abstract
This study describes the continuity of visiting pharmacist services and investigates factors associated with service discontinuation in a homebound older population in Japan. This retrospective cohort study used medical and long-term care claims data from older adults aged ≥ 65 years in a city in Tokyo, Japan, who began to receive visiting pharmacist services between April 2014 and March 2019. Participants were followed until service cessation (defined as the absence of service claims for 2 consecutive months) or 12 months from initiation. Reasons for cessation were categorized into death, relocation, hospitalization/institutionalization, or discontinuation based on claims data. Multivariable competing-risk Cox regression analysis determined factors associated with discontinuation. Death and hospitalization/institutionalization were considered competing risks, and relocation was considered non-informative censoring. The study included 3952 older adults, with 353 (8.9%) having terminal cancer. The median time to any-cause cessation was 11 and 2 months for all participants and those with terminal cancer, respectively. Death was the most common reason for cessation, with a 12-month cumulative incidence of 0.25 (95% confidence interval: 0.24-0.27). Factors associated with a lower likelihood of discontinuation included higher long-term care need levels, polypharmacy of more than five medications, recent hospitalization, and cancer diagnosis. Conversely, living at home compared to residential facilities, ischemic heart disease, and receiving services from pharmacies providing 24-h support were linked to a higher discontinuation risk. This study enhances the current understanding of continuity in visiting pharmacist services for older adults. Care should be tailored, considering factors influencing service duration and potential discontinuation.
Keywords: cancer; claims data; home visits; long‐term care; pharmacists.
© 2025 The Author(s). Pharmacology Research & Perspectives published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley & Sons Ltd.
Conflict of interest statement
Shota Hamada belongs to an endowed chair funded by donations from Hakue Technology, PROUMED, Japan BioProducts, Towa Pharmaceutical, Yellow Eight, and Sugi Holdings. Shota Hamada received research funding from SOMPO Care Inc. outside of this work. The remaining authors declare no conflicts of interest.
Figures



Similar articles
-
Factors associated with the introduction of visiting-pharmacist services in older adults in Japan: A nested case-control study.Geriatr Gerontol Int. 2024 Apr;24(4):344-351. doi: 10.1111/ggi.14838. Epub 2024 Feb 21. Geriatr Gerontol Int. 2024. PMID: 38379434
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- World Health Organization , “Global Strategy and Action Plan on Ageing and Health. Geneva,” (2017), https://www.who.int/publications/i/item/9789241513500.
-
- Schenk A., Eckardt‐Felmberg R., Steinhagen‐Thiessen E., and Stegemann S., “Patient Behaviour in Medication Management: Findings From a Patient Usability Study That May Impact Clinical Outcomes,” British Journal of Clinical Pharmacology 86, no. 10 (2020): 1958–1968, 10.1111/bcp.13946. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous